Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …

…, S Lawson-Tovey, JW Liew, L Ljung… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year …

…, C Dackhammar, F Akre, K Forslind, L Ljung… - The Lancet, 2009 - thelancet.com
Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We
aimed to compare addition of conventional disease-modifying antirheumatic drugs (…

[HTML][HTML] Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

L Innala, B Möller, L Ljung, S Magnusson… - Arthritis research & …, 2011 - Springer
Introduction Co-morbidity and mortality due to cardiovascular disease (CVD) are increased
in patients with rheumatoid arthritis (RA). Most published studies in this field are retrospective …

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study

…, A Kajalainen, JG Brun, A Proven, L Ljung… - The Journal of …, 2012 - jrheum.org
Objective. To study the efficacy of anakinra versus disease-modifying antirheumatic drugs (DMARD)
in refractory adult-onset Still’s disease (AOSD). Methods. In a 24-week study, 22 …

[HTML][HTML] Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

L Innala, E Berglin, B Möller, L Ljung, T Smedby… - Arthritis research & …, 2014 - Springer
Introduction Disease activity, severity and comorbidity contribute to increased mortality in
patients with rheumatoid arthritis (RA). We evaluated the impact of age at disease onset on …

[HTML][HTML] Co-morbidity in patients with early rheumatoid arthritis-inflammation matters

L Innala, C Sjöberg, B Möller, L Ljung… - Arthritis research & …, 2016 - Springer
Background Patients with rheumatoid arthritis (RA) suffer from co-morbidities that contribute
to a shortened lifespan. Inflammation is important for the development of cardiovascular …

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis

L Ljung, S Rantapää-Dahlqvist… - Annals of the …, 2016 - ard.bmj.com
Objectives Whether the increased risk of comorbidities, such as cardiovascular disease, in
rheumatoid arthritis (RA) can be reverted by particular antirheumatic therapies, or response to …

Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks

M Holmqvist, L Ljung, J Askling - Annals of the Rheumatic Diseases, 2017 - ard.bmj.com
Background Acute coronary syndrome (ACS) and other cardiovascular diseases are the main
drivers of the increased morbidity and preterm mortality in rheumatoid arthritis (RA). ACS …

Mortality following new-onset rheumatoid arthritis: has modern rheumatology had an impact?

M Holmqvist, L Ljung, J Askling - Annals of the rheumatic diseases, 2018 - ard.bmj.com
Objective To investigate if, and when, patients diagnosed with rheumatoid arthritis (RA) in
recent years are at increased risk of death. Methods Using an extensive register linkage, we …

[HTML][HTML] Abdominal obesity, gender and the risk of rheumatoid arthritis–a nested case–control study

L Ljung, S Rantapää-Dahlqvist - Arthritis research & therapy, 2016 - Springer
Background The risk of development of rheumatoid arthritis (RA) could be affected by immune
activation in obesity. Our objective was to evaluate the association between obesity in …